| (Values in U.S. Thousands) | Jun, 2022 | Jun, 2021 | Jun, 2020 | Jun, 2019 | Dec, 2025 |
| Sales | 10 | 40 | 240 | 0 | 0 |
| Sales Growth | -75.00% | -83.33% | unch | unch | unch |
| Net Income | -5,150 | -9,030 | -4,290 | -30 | 0 |
| Net Income Growth | +42.97% | -110.49% | -14,200.47% | unch | unch |
Global Wholehealth Partners Corp (GWHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits principally in the United States. The Company sells and develop in-vitro diagnostic products, including rapid diagnostic tests, such as the COVID-19 Test, rapid whole blood Ebola Test, whole blood Zika test, blood rapid TB test and other tests. Global WholeHealth Partners Corporation is based in San Clemente, California.
Fiscal Year End Date: 06/30